(NVST) Envista Holdings - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29415F1049

NVST: Dental Implants, Orthodontic Products, Digital Imaging, Dental Equipment

Envista Holdings Corporation (NYSE: NVST) is a leading global dental products company that designs, manufactures, and markets a wide range of innovative dental solutions. Headquartered in Brea, California, the company was established in 2018 and operates in over 40 countries worldwide, including the United States, China, and other international markets. Envistas product portfolio spans two primary segments: Specialty Products & Technologies and Equipment & Consumables. The company serves various dental professionals, including oral surgeons, prosthodontists, periodontists, orthodontists, and general dentists, as well as dental laboratories, clinics, and hospitals.

The Specialty Products & Technologies segment focuses on advanced dental solutions, including implant systems, guided surgery systems, and biomaterials. It also offers orthodontic products such as brackets, wires, clear aligners, and retainers. This segment is complemented by a suite of digital solutions, including the DTX Studio software platform, which supports implant planning, lab workflows, and clinical applications. Products in this segment are marketed under well-known brands like Nobel Biocare, Implant Direct, Damon, and Ormco.

The Equipment & Consumables segment provides essential dental supplies and equipment, such as digital imaging systems, endodontic systems, restorative materials, and infection prevention products. This segment also includes visualization and magnification systems, impression materials, and bonding agents. Key brands in this segment include Kerr, Dexis, Metrex, and Sybron Endo, catering to the daily operational needs of dental offices and clinics.

From a technical perspective, NVST is currently trading at $15.96, below its 20-day and 50-day moving averages of $15.78 and $17.49, respectively, but above its 200-day moving average of $18.66. The stock exhibits moderate volatility with an ATR of 0.85 and an average 20-day volume of 3.12 million shares. This indicates potential short-term resistance near the 50-day SMA and support near the 200-day SMA.

Fundamentally, Envista has a market capitalization of $2.75 billion, with a forward P/E ratio of 15.65, indicating expectations for earnings growth. The P/B ratio of 0.94 suggests the stock is undervalued relative to its book value, while the P/S ratio of 1.10 reflects a reasonable valuation for its revenue generation. However, the negative return on equity (RoE) of -38.12% raises concerns about profitability and efficiency.

3-Month Forecast: Based on the technical and fundamental data, NVST is likely to face resistance near its 50-day SMA ($17.49) and may experience selling pressure if it fails to breach this level. Support is expected near the 200-day SMA ($18.66), though the stocks current price is below this level, suggesting potential volatility. The negative RoE could weigh on investor sentiment, but the reasonable forward P/E and P/B ratios may attract value investors. Expect a trading range between $14.50 and $18.00 over the next three months, with potential upside if the company demonstrates improved profitability.

Ticker Symbol: NVST Exchange: NYSE Type: common stock Country Origin: United States GICS Sub Industry: Health Care Equipment Average Volume 20d: 3122818 Last Price: 15.96 SMA 20: 15.78 SMA 50: 17.49 SMA 200: 18.66 ATR: 0.85 Market Cap: 2751.56M USD P/E: None P/E Forward: 15.65 P/B: 0.94 P/S: 1.10 RoE: -38.12

Additional Sources for NVST Stock

NVST Stock Overview

Market Cap in USD 2,814m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Health Care Equipment
IPO / Inception 2019-09-18

NVST Stock Ratings

Growth Rating -15.3
Fundamental -31.4
Dividend Rating 0.0
Rel. Strength -3.03
Analysts 3.29/5
Fair Price Momentum 16.10 USD
Fair Price DCF 33.37 USD

NVST Dividends

No Dividends Paid

NVST Growth Ratios

Growth Correlation 3m -75.5%
Growth Correlation 12m 7.8%
Growth Correlation 5y -56.5%
CAGR 5y 0.16%
CAGR/Max DD 5y 0.00
Sharpe Ratio 12m -1.15
Alpha -17.87
Beta 0.865
Volatility 43.35%
Current Volume 1750.3k
Average Volume 20d 2301.9k
What is the price of NVST stocks?
As of May 11, 2025, the stock is trading at USD 17.59 with a total of 1,750,284 shares traded.
Over the past week, the price has changed by +3.53%, over one month by +7.00%, over three months by -17.15% and over the past year by -8.77%.
Is Envista Holdings a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Envista Holdings (NYSE:NVST) is currently (May 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -31.35 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVST as of May 2025 is 16.10. This means that NVST is currently overvalued and has a potential downside of -8.47%.
Is NVST a buy, sell or hold?
Envista Holdings has received a consensus analysts rating of 3.29. Therefor, it is recommend to hold NVST.
  • Strong Buy: 3
  • Buy: 0
  • Hold: 10
  • Sell: 0
  • Strong Sell: 1
What are the forecast for NVST stock price target?
According to ValueRays Forecast Model, NVST Envista Holdings will be worth about 17.6 in May 2026. The stock is currently trading at 17.59. This means that the stock has a potential downside of -0.23%.
Issuer Forecast Upside
Wallstreet Target Price 19.8 12.5%
Analysts Target Price 21.3 21.3%
ValueRay Target Price 17.6 -0.2%